The finding that miR-155 expression was increased in human SMCs following FcεRI crosslinking was intriguing because miR-155 is known to be involved in the immune response (22) and has been implicated in allergic disease in humans including atopic dermatitis (23), allergic rhinitis (24), and asthma (25). The gene discussed is FCER1A; the disease is allergic disease.